Chicago Equity Partners’s Innospec IOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$1.19M Buy
17,116
+2,056
+14% +$188K 0.12% 249
2019
Q4
$1.56M Sell
15,060
-12,105
-45% -$1.16M 0.09% 335
2019
Q3
$2.42M Buy
27,165
+8,785
+48% +$787K 0.12% 262
2019
Q2
$1.68M Buy
+18,380
New +$1.55M 0.07% 377
2016
Q4
Sell
-13,925
Closed -$847K 757
2016
Q3
$847K Sell
13,925
-37,110
-73% -$2.06M 0.02% 458
2016
Q2
$2.35M Buy
51,035
+9,220
+22% +$436K 0.07% 243
2016
Q1
$1.81M Sell
41,815
-4,240
-9% -$196K 0.05% 271
2015
Q4
$2.5M Buy
46,055
+28,025
+155% +$1.55M 0.07% 223
2015
Q3
$839K Buy
+18,030
New +$827K 0.02% 398

Other funds holding IOSP

Chicago Equity Partners's IOSP Position: Q1 2020 in Review

Chicago Equity Partners increased its Innospec (IOSP) stake by 14% in Q1 2020, buying an estimated $188K and bringing the position to 17,116 shares worth $1.19M. The position accounts for 0.12% of the portfolio, ranked #249.

Chicago Equity Partners first reported a position in IOSP in Q3 2015 and has held it in 9 quarters since. The position peaked at $2.5M in Q4 2015. 180 funds tracked by Wall St. Rank hold IOSP as of Q1 2020.

  • Chicago Equity Partners held 17,116 shares of Innospec worth $1.19M as of Q1 2020.
  • Chicago Equity Partners bought 2,056 Innospec shares in Q1 2020, an estimated $188K.
  • Innospec made up 0.12% of Chicago Equity Partners's portfolio in Q1 2020, its #249 holding.
  • Chicago Equity Partners first reported a position in Innospec in Q3 2015 and has held it in 9 quarters since.
  • Chicago Equity Partners's Innospec position peaked at $2.5M in Q4 2015.
  • 180 funds tracked by Wall St. Rank held Innospec as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.